Tirzepatide is a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://mattieaedk756679.bloggip.com/40928969/tirzepatide-a-game-changer-for-type-2-diabetes